Skip to content
MedsAcross

Brand family

Aplenzin

Bupropion · Bausch Health
United States
Presentations
3
Markets
1

Aplenzin is a brand of Bupropion marketed by Bausch Health, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Bupropion
Brand owner
Bausch Health
Registered in
United States
Strengths and forms
174 mg extended-release tablet, 348 mg extended-release tablet, 522 mg extended-release tablet

All presentations

MedicineManufacturerRegisterAvailability
Aplenzin 174 mg extended-release tabletOralBausch HealthUS FDAAvailable on request
Aplenzin 348 mg extended-release tabletOralBausch HealthUS FDAAvailable on request
Aplenzin 522 mg extended-release tabletOralBausch HealthUS FDAAvailable on request

Equivalent brands

Other brands of Bupropion.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Aplenzin

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.